nopzon
.com
Bluesky Explorer
Search
Home
Trending
Search
Advertisement · 728 × 90
#
Hashtag
#Y220C
Advertisement · 728 × 90
Ferran Fece de la Cruz
@ferranfececruz.bsky.social
1 month ago
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors | NEJM
Rezatapopt is an investigational, first-in-class, oral, selective p53 reactivator that specifically binds to Y220C-mutated p53, which stabilizes p53 in its wild-type conformation and restores its f...
Rezatapopt for TP53 Y220C–Mutated Tumors. Game changer!
#Y220C
#Rezatapopt
#PYNNACLE
@nejm.org
1
0
0
0